Nurami Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $30M

  • Investors
  • 15

Nurami General Information

Description

Developer of biomaterials and nanofiber-based matrix designed to improve patient outcomes in various surgical procedures. The company's matrices combine porous scaffold for tissue regeneration enhancement with a novel temperature-sensitive sealant to prevent the entry of pathogens and CSF leaks, enabling surgeons to answer the unmet needs of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 36 Ha-Namal Street
  • Haifa 3303203
  • Israel
+972
Primary Industry
Surgical Devices
Other Industries
Drug Discovery
Corporate Office
  • 36 Ha-Namal Street
  • Haifa 3303203
  • Israel
+972

Nurami Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nurami Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC 03-Mar-2025 $30M Completed Generating Revenue
14. Grant 16-Jul-2024 Completed Generating Revenue
13. Later Stage VC 16-Jul-2024 Completed Generating Revenue
12. Accelerator/Incubator 03-Jun-2024 Completed Generating Revenue
11. Grant 01-Jan-2023 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Grant 01-Jan-2021 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Later Stage VC (Series B) 02-Nov-2020 $6M $9.7M Completed Generating Revenue
6. Grant 01-Jan-2020 $1.2M $3.74M Completed Generating Revenue
To view Nurami’s complete valuation and funding history, request access »

Nurami Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A
Ordinary A
To view Nurami’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nurami Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biomaterials and nanofiber-based matrix designed to improve patient outcomes in various surgical procedures
Surgical Devices
Haifa, Israel
22 As of 2025

Paramus, NJ
 

Portage, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nurami Competitors (3)

One of Nurami’s 3 competitors is Regenity, a Private Equity-Backed company based in Paramus, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenity Private Equity-Backed Paramus, NJ
Stryker Formerly VC-backed Portage, MI
Integra Lifesciences Corporation Princeton, NJ
You’re viewing 3 of 3 competitors. Get the full list »

Nurami Patents

Nurami Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220273842-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019
EP-4003437-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019
CA-3144451-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019
AU-2020316756-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019
EP-4003437-A4 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019 A61L24/0015
To view Nurami’s complete patent history, request access »

Nurami Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nurami Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Venture Capital Minority
Iron Nation Venture Capital Minority
MedTech Innovator Accelerator/Incubator
Almeda Ventures Venture Capital Minority
GlenRock Israel Growth/Expansion Minority
You’re viewing 5 of 15 investors. Get the full list »

Nurami FAQs

  • When was Nurami founded?

    Nurami was founded in 2014.

  • Where is Nurami headquartered?

    Nurami is headquartered in Haifa, Israel.

  • What is the size of Nurami?

    Nurami has 22 total employees.

  • What industry is Nurami in?

    Nurami’s primary industry is Surgical Devices.

  • Is Nurami a private or public company?

    Nurami is a Private company.

  • What is Nurami’s current revenue?

    The current revenue for Nurami is .

  • How much funding has Nurami raised over time?

    Nurami has raised $39.7M.

  • Who are Nurami’s investors?

    European Innovation Council, Iron Nation, MedTech Innovator, Almeda Ventures, and GlenRock Israel are 5 of 15 investors who have invested in Nurami.

  • Who are Nurami’s competitors?

    Regenity, Stryker, and Integra Lifesciences are competitors of Nurami.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »